Defence Bioengineering and Electromedical Laboratory

EPI’s Alpha-Stim AID Offered for First Time in the UK’s NHS Primary Care

Retrieved on: 
Thursday, June 29, 2023

“Antidepressants and talk therapy treatments aren’t always acceptable or effective for everyone, and Alpha-Stim AID offers an additional therapeutic option.

Key Points: 
  • “Antidepressants and talk therapy treatments aren’t always acceptable or effective for everyone, and Alpha-Stim AID offers an additional therapeutic option.
  • The Alpha-Stim AID is a non-drug cranial electrotherapy stimulation (CES) device that is CE marked and U.S. FDA cleared to safely and effectively treat anxiety.
  • The use of Alpha-Stim AID in Northamptonshire is expected to be a catalyst for widespread use throughout the rest of the United Kingdom.
  • “The positive results and feedback from the people who used Alpha-Stim AID during the research project surpassed my expectations.

Electromedical Products International Forms Scientific Advisory Board

Retrieved on: 
Thursday, April 6, 2023

Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim® technology , announced today the formation of its Scientific Advisory Board (SAB) comprising leading clinicians and researchers in neurology, psychiatry and neurostimulation.

Key Points: 
  • Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim® technology , announced today the formation of its Scientific Advisory Board (SAB) comprising leading clinicians and researchers in neurology, psychiatry and neurostimulation.
  • The SAB will work closely with EPI’s leadership team to provide scientific and clinical input into the company’s clinical trials in non-invasive brain stimulation as well as potential expansion into additional therapeutic indications.
  • The SAB will also advise Pulvinar Neuro, a wholly owned subsidiary of EPI, on the development of its neurotechnology portfolio.
  • Dr. Frohlich has deep expertise in neurotechnology development, translational non-invasive brain stimulation research, and clinical trials in psychiatry and neurology.

Electromedical Technologies Announces Preliminary Unaudited Revenue for Q4 and FY 2022 and update on operations

Retrieved on: 
Tuesday, March 14, 2023

Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.

Key Points: 
  • Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.
  • During the three months ended Dec 31, preliminary revenue increased 79% on a quarterly year-over-year basis and 51% on a sequential quarterly basis.
  • We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance.
  • And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."

Electromedical Products International, Inc., Awards First Annual Innovative Young Investigator in Brain Stimulation Award

Retrieved on: 
Wednesday, February 15, 2023

Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim® technology , announced today that it has awarded its first annual Innovative Young Investigator in Brain Stimulation Award to Tobias Schwippel, M.D.

Key Points: 
  • Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim® technology , announced today that it has awarded its first annual Innovative Young Investigator in Brain Stimulation Award to Tobias Schwippel, M.D.
  • EPI established this award to recognize and nurture excellence in the field of non-invasive brain stimulation.
  • Recipients are early-career researchers making notable, innovative contributions in the field who demonstrate the potential to be leaders in clinical research and practice.
  • Dr. Tobias Schwippel, Director of Clinical Research at the Carolina Center for Neurostimulation , focuses on non-invasive brain stimulation research in psychiatry.

Sika Health and Electromedical Announce Partnership Enabling HSA/FSA Payments on Electromedical eCommerce Site

Retrieved on: 
Wednesday, January 25, 2023

SCOTTSDALE, Ariz., Jan. 25, 2023 /PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, and Sika Health, an HSA/FSA payment facilitator for eCommerce merchants, are pleased to announce a partnership enabling the direct acceptance of HSA/FSA payments on the Electromedical eCommerce website (electromedtech.com).

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 25, 2023 /PRNewswire/ -- Electromedical Technologies, Inc. (OTC-QB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, and Sika Health, an HSA/FSA payment facilitator for eCommerce merchants, are pleased to announce a partnership enabling the direct acceptance of HSA/FSA payments on the Electromedical eCommerce website ( electromedtech.com ).
  • "This is a game-changer in terms of our ability to facilitate payments and tap into greater affordability without sacrificing margins," remarked Matthew Wolfson, CEO and Founder of Electromedical.
  • "Sika's payment technology is seamless and easy to use, and the Sika team has been exceptional to work with."
  • The partnership between Sika Health and Electromedical aims to close this gap and offer patients a seamless way to take full advantage of their benefits.

Electromedical Technologies Introduces the WellnessPro Infinity™

Retrieved on: 
Tuesday, November 1, 2022

SCOTTSDALE, Ariz., Oct. 31, 2022 /PRNewswire/ -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, is very excited to introduce its new next-generation flagship device, the WellnessPro Infinity™.

Key Points: 
  • SCOTTSDALE, Ariz., Oct. 31, 2022 /PRNewswire/ -- InvestorsHub NewsWire -- Electromedical Technologies, Inc. ( OTCQB: EMED ) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain through frequency and electro-modulation, is very excited to introduce its new next-generation flagship device, the WellnessPro Infinity.
  • "The WellnessPro Infinity will set an entirely new standard in the Bioelectronics marketplace" remarked Electromedical Founder and CEO, Matthew Wolfson.
  • The NEW WellnessPro Infinity device features:
    One compact device that encompasses ALL electrotherapy modalities.
  • Our goal is to go to market with the WellnessPro Infinity first, then shortly after releasing the POD upon FDA 510k clearance."

Electromedical's Flagship WellnessPro Plus Technology on Exhibit This Week at PAINWeek 2022 in Las Vegas from Sep 6-9

Retrieved on: 
Thursday, September 8, 2022

SCOTTSDALE, Ariz, Sept. 8, 2022 /PRNewswire/ -- Electromedical Technologies, Inc. (OTCQB: EMED) ("Electromedical" or the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable, and acute pain by using frequencies and electro-modulation, is excited to announce that the Company is exhibiting its flagship product, the WellnessPro Plus, at the world renowned PAINWeek national conference event (www.painweek.org) this week from September 6 thru September 9 at the Cosmopolitan Hotel in the heart of the Las Vegas strip.

Key Points: 
  • PAINWeek 2021 was the largest pain conference in the United States, drawing over 1,500 attendees in the pain management field.
  • Interested attendees are invited to visit the Electromedical booth and try the WellnessPro Plus firsthand to experience the magic of drug-free pain relief.
  • "PAINWeek offers us the perfect venue to demonstrate the power and efficacy of our core technology," remarked Matthew Wolfson, Founder and CEO of Electromedical.
  • PAINWeek has been a leading resource for frontline practitioners treating acute and chronic pain for over 15 years.

BizVibe Adds New Company Insights for 10,000+ Navigational, Measuring, Electromedical, and Control Instrument Companies | Risk Evaluation | Regional Analysis | Similar Companies | Financials and Management Team

Retrieved on: 
Wednesday, August 3, 2022

Regardless of their economic development status, most countries continue to invest significantly in the power sector, creating a robust structural demand base for electrical equipment and related instruments.

Key Points: 
  • Regardless of their economic development status, most countries continue to invest significantly in the power sector, creating a robust structural demand base for electrical equipment and related instruments.
  • While some projects stopped for a few months, many others were canceled or postponed for longer periods.
  • The situation has created significant declines in orders for various instruments and equipment.
  • Some of the public and private navigational, measuring, electromedical, and control instrument companies on BizVibe include:

Brian Burke Joins Electromedical Products International, Inc. as President

Retrieved on: 
Friday, July 22, 2022

MINERAL WELLS, Texas, July 22, 2022 /PRNewswire-PRWeb/ -- Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim technology, has announced Brian Burke as President. Mr. Burke comes to EPI with extensive experience in the medical technology industry, including over 15 years in startup, private equity and public company environments, in the orthopedic, spine, and maxillofacial-dental sectors.

Key Points: 
  • Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim technology, has announced Brian Burke as President.
  • MINERAL WELLS, Texas, July 22, 2022 /PRNewswire-PRWeb/ -- Electromedical Products International, Inc. (EPI), manufacturer of Alpha-Stim technology, has announced Brian Burke as President.
  • "Brian is a proven leader across all areas of management in a medical technology company with considerable experience.
  • Electromedical Products International, Inc. (EPI) was formed in 1981 to develop, manufacture and market Alpha-Stim technology worldwide.

Electromedical Technologies Adds Former Aerospace CEO and Current Management Expert Lee Benson to Board of Directors

Retrieved on: 
Tuesday, June 14, 2022

Lee can help us reach higher levels of growth, culture and execution."

Key Points: 
  • Lee can help us reach higher levels of growth, culture and execution."
  • Lee Benson started his career as the first employee in a small company providing specialty electroplating services to repair aircraft components.
  • Benson sold Able Aerospace to global powerhouse Textron Aviation in a Nine-figure deal.
  • After he secured the deal, Lee founded ETW to help other businesses achieve maximum success and profit from his experience and expertise.